Miguel Angel Burch

About this provider

Miguel Angel Burch is listed in general surgery in Marina Del Rey, CA. Reported medical education includes Virginia Commonwealth University, School Of Medicine (1999).

Reported procedures

• Gastric sleeve Source ↗
• duodenal switch Source ↗
• biliary pancreatic diversion Source ↗
• gastric band Source ↗
• Roux-en-Y bypass Source ↗
• revisional bariatric surgery Source ↗

Source-reported information; confirm current details directly.

Education & training

• VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE · 1999 Source ↗

Source-reported information; confirm current details directly.

Reported credentials

• Allergy & Immunology Source ↗
• Surgery Source ↗

Source-reported information; confirm current details directly.

Reported affiliations

• CEDARS-SINAI MEDICAL CARE FOUNDATION Source ↗
• CEDARS-SINAI MEDICAL CENTER Source ↗

Source-reported information; confirm current details directly.

Selected publications

• No added risk: national outcomes of magnetic sphincter explant with hiatal hernia repair and fundoplication. · 2026 Source ↗
• Laparoscopic versus Robotic-Assisted Heller Myotomy for the Treatment of Achalasia: An ACS-NSQIP Analysis. · 2026 Source ↗
• Management of gastric cancer peritoneal metastasis: International Gastric Cancer Association GCPM Working Group consensus statements. · 2026 Source ↗
• Pulmonary immunohistochemical markers may be positive in gastric adenocarcinomas associated with autoimmune metaplastic atrophic gastritis. · 2026 Source ↗
• Timeliness of Care for Nonelective Cholecystectomy: Comparison of Surgical Practice Models. · 2025 Source ↗
• Real-Time Pain Control Education After Outpatient General Surgery: A Randomized Controlled Trial. · 2025 Source ↗
• Clinicopathologic findings in a cohort of metastases to the stomach. · 2024 Source ↗
• Enhancing Lymph Node Yield in Gastric Cancer Resection: Impact of Back Table Dissection on Number of Lymph Node Examined. · 2024 Source ↗
• Incorporating Robotic Cholecystectomy in an Acute Care Surgery Practice Model is Feasible. · 2024 Source ↗
• Challenges With Robot-Assisted Surgery Setup for Complex Minimally Invasive Upper Gastrointestinal Surgery. · 2024 Source ↗
• Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing? · 2023 Source ↗
• Blinded Intraoperative Quantitative Indocyanine Green Metrics Associate With Intestinal Margin Acceptance in Colorectal Surgery. · 2024 Source ↗
• Rising Incidence of Non-Cardia Gastric Cancer among Young Women in the United States, 2000-2018: A Time-Trend Analysis Using the USCS Database. · 2023 Source ↗
• Contemporary Cancer Program Practice Profile Report Compliance Rates for Gastric Cancer: A National Cancer Database Analysis. · 2023 Source ↗
• Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery. · 2023 Source ↗
• 30-Day Postoperative Outcomes in Patients With Limited Mobility - A Propensity Score-Matched Comparative Analysis. · 2022 Source ↗
• Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model. · 2022 Source ↗
• Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers. · 2022 Source ↗
• Operative approach and case volume are associated with negative resection margins for adrenocortical carcinoma. · 2022 Source ↗
• Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer. · 2022 Source ↗
• Management of Postoperative Complications Following Bariatric and Metabolic Procedures. · 2021 Source ↗
• A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. · 2021 Source ↗
• Complete response to neoadjuvant pembrolizumab and capecitabine in microsatellite stable, Epstein-Barr virus-positive, locally advanced gastric adenocarcinoma: case report. · 2021 Source ↗
• Adrenocortical Carcinoma: The Value of Lymphadenectomy. · 2022 Source ↗
• Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. · 2022 Source ↗
• Disparities and survival in newly diagnosed gastric cancer in Hispanic patients in the United States: a propensity score matched analysis. · 2021 Source ↗
• Factors Associated with Non-Operative Management of Resectable Adrenocortical Carcinoma. · 2021 Source ↗
• Conversion of laparoscopic sleeve gastrectomy to Roux-en-Y gastric bypass: patterns predicting persistent symptoms after revision. · 2021 Source ↗
• Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. · 2020 Source ↗
• Patient Expectations After Collis Gastroplasty. · 2020 Source ↗
• Association of Wearable Activity Monitors With Assessment of Daily Ambulation and Length of Stay Among Patients Undergoing Major Surgery. · 2019 Source ↗
• Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. · 2019 Source ↗
• Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement. · 2018 Source ↗
• Variability of Directly Measured First-Pass Hepatic Insulin Extraction and Its Association With Insulin Sensitivity and Plasma Insulin. · 2018 Source ↗
• Covered Esophageal Stenting Is Effective for Symptomatic Gastric Lumen Narrowing and Related Complications Following Laparoscopic Sleeve Gastrectomy. · 2017 Source ↗
• The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. · 2017 Source ↗
• Intestinal methane production is associated with decreased weight loss following bariatric surgery. · 2016 Source ↗
• Single-stage revision from gastric band to gastric bypass or sleeve gastrectomy: 6- and 12-month outcomes. · 2016 Source ↗
• Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia. · 2014 Source ↗
• Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. · 2015 Source ↗
• Splenic malignancy: a minimally invasive approach. · 2005 Source ↗

Source-reported information; confirm current details directly.

Insurance reported

Aetna

Anthem

Blue Cross Blue Shield

Blue Cross Blue Shield of California

Carefirst Blue Cross Blue Shield

Cigna

Commercial Insurance Company

Delta Health System

First Health

Humana

Multiplan

UnitedHealthcare

Reported in source records. Confirm the exact plan, network and procedure with the practice and insurer. Logos identify brands; they do not establish participation.